Iron is an essential nutrient for nearly all organisms, but iron overdose is toxic. The human commensalpathogenic fungus Candida albicans traverses host niches with markedly different iron availability. During systemic infection, C. albicans must activate the high-affinity iron permease Ftr1 to acquire iron sequestered by the host's iron-withholding defense and suppresses iron uptake while residing in the iron-rich gut to avoid toxicity. Ftr1 associates with a ferroxidase to form an iron transporter. C. albicans contains four permeases and five ferroxidase homologs, suggesting 20 possible subunit combinations. Here, we investigated the iron-dependent expression, cellular localization and interacting partners of all permeases and ferroxidases and the significance of each subunit for gastrointestinal colonization and systemic infection in mice. We uncovered three distinct patterns of iron-dependent expression and highly flexible ferroxidase-permease partnerships, which underlie a dynamic iron transport system that can be deftly tuned according to iron availability. We found functional differentiation as well as redundancy among the ferroxidases and permeases during both gastrointestinal colonization and bloodstream infection. We propose that C. albicans possesses a sophisticated iron acquisition and utilization system befitting its commensal-pathogenic lifestyle. Our findings reveal new possibilities for medical intervention of C. albicans infection.
Introduction
Iron is an essential nutrient for almost all living organisms (Howard, 1999; Lan et al., 2004; Philpott, 2006) . The extreme variability of the redox potential of ferrous (Fe 12 ) and ferric (Fe 13 ) iron underlies its role in many essential physiological processes such as DNA replication, oxygen transport and electron delivery (Philpott, 2006) . In spite of being the fourth most abundant element on Earth, iron exists mostly in insoluble forms, rendering its bioavailability extremely low. Conversely, iron can be toxic as it catalyzes the production of reactive oxygen species that can severely damage biological molecules such as nucleic acids, proteins and lipids (Crichton and Ward, 1998) . Hence, all organisms possess exquisite strategies to acquire iron and control its levels. Many species, such as mammals, have even evolved mechanisms to sequester iron to prevent the growth of microbial invaders (Collins, 2008; Sutak et al., 2008) . This iron-withholding defense effectively reduces the free iron concentration in the human body to a level way below the minimal requirement for microbial growth. In the struggle for survival, successful pathogens have evolved powerful counteractive strategies to acquire iron (Nairz et al., 2010; Caza and Kronstad, 2013) . Many human pathogens can extract iron from host ironbinding proteins such as hemoglobin, transferrin and ferritin. Commensal-pathogens must overcome additional challenges. Trillions of microbial cells reside in the gastrointestinal (GI) tract (Eckburg et al., 2005) , along which iron availability varies dramatically. The high acidity of the stomach significantly increases the solubility of ferric iron, allowing it to reach potentially toxic levels. In contrast, the colon could be iron-limiting because of its neutral pH which reduces iron solubility and the high density of bacteria all competing for micronutrients (Kortman et al., 2014) . Recent findings suggest that at least parts of the gut are iron-limiting: first, iron fortification increases the abundance of pathogenic bacteria in the gut (Kortman et al., 2014; Jaeggi et al., 2015) , and second, a fungal strain lacking a key transcription factor that is active only under iron shortage showed reduced ability of gut colonization (Chen et al., 2011) . Thus, commensal-pathogens must be able to deal with both iron excess and limitation when traversing across host niches that have markedly different iron availability.
The yeast Candida albicans is the most prevalent fungal pathogen as well as a member of the microbiota of humans (Brown et al., 2012) . It colonizes the GI tract as a commensal and travels through the bloodstream during systemic infection. Previous studies have revealed that this commensal-pathogen possesses an intricate iron uptake regulatory network not seen in other fungi, important for adaptation when shuttling between ironreplete and limiting niches (Chen et al., 2011) . C. albicans has multiple mechanisms for extracting iron from several iron-containing proteins of the host (Tanaka et al., 1997; Weissman and Kornitzer, 2004; Knight et al., 2005; Almeida et al., 2008; Weissman et al., 2008; Almeida et al., 2009; Kuznets et al., 2014) . It can also use iron bound to siderophores, iron chelators produced by other bacteria or fungi (Hu et al., 2002) . A key component of the iron uptake system essential for systemic infection is a high-affinity iron permease Ftr1 (Ramanan and Wang, 2000) . It is a plasma membrane (PM) protein responsible for iron import (Fang and Wang, 2002; Severance et al., 2004) . Ftr1 has a homolog, Ftr2, which is however not required for systemic infection (Ramanan and Wang, 2000) . Interestingly, the expression of the two genes is regulated in an opposite manner: FTR1 is activated while FTR2 repressed by iron shortage (Ramanan and Wang, 2000) .
Ftr1 is highly conserved in fungi and was first discovered in Saccharomyces cerevisiae for its essentiality for growth in iron-limiting media (Stearman et al., 1996) . Later, a homolog, Fth1, was identified which resides in the vacuolar membrane (VM) transporting storage iron into the cytoplasm (Urbanowski and Piper, 1999) . Characterization of other iron uptake mutants revealed that a permease must associate with a ferroxidase to form a functional transporter Dancis et al., 1994; Spizzo et al., 1997; Singh et al., 2006) . The ferroxidase-permease partnership was found to be specific: Ftr1 interacts only with the Fet3 ferroxidase while Fth1 with Fet5 (Urbanowski and Piper, 1999; Singh et al., 2006) . Subunit exchanges do not occur between the two complexes. The ferroxidase-permease interaction starts early in the ER during protein synthesis and is required for the correct folding, posttranslational modification and trafficking of the transporter to the final cellular destination (Urbanowski and Piper, 1999; Singh et al., 2006) . Unlike S. cerevisiae that has two iron permeases and two ferroxidases, C. albicans possesses five ferroxidase genes annotated as FET3, FET31, FET33, FET34 and FET99 and four permease genes FTR1, FTR2, FTH1 and FTH2 (Muzzey et al., 2013) , suggesting that C. albicans may assemble multiple high-affinity iron transporters. If not restricted by the specific ferroxidasepermease partnership, there would be 20 possible subunit combinations.
In this study, we conducted co-localization and interaction analyses of all ferroxidases and permeases of C. albicans. We found that although the permeases exhibit strict specificity to the PM or VM, the ferroxidasepermease partnership is flexible which allows the formation of up to 18 iron transporter complexes. We examined mutants lacking one or more ferroxidase or permease genes for their ability to colonize the gut and cause systemic infection in mice and observed functional differentiation as well as redundancy. We propose that the presence of multiple ferroxidases and permeases, their iron-dependent differential expression and the flexible ferroxidase-permease partnership create a highly versatile and dynamic iron transport system, enabling C. albicans to deftly adapt to host niches with different levels of iron bioavailability.
Results
Distinct iron-dependent regulation patterns of iron permease and ferroxidase genes in C. albicans Although the iron-dependent expression of subsets of iron permease and ferroxidase genes of C. albicans had been investigated in several studies using different methods (Ramanan and Wang, 2000; Lan et al., 2004; Xu et al., 2015) , it remained difficult to compare their relative expression levels. In this study, we first quantified by qPCR the expression of all ferroxidase and permease genes in the wild-type (WT) strain SC5314 in response to iron concentration. We carefully designed oligonucleotide primers to differentiate the highly similar homologs. Figure 1 presents the relative transcript levels of all genes. The analysis revealed three distinct regulation patterns. (a) The expression of FTR1, FTH1, FET31, FET34 and FET99 was highest under iron-deprived conditions and decreased progressively with the increase of iron concentration; (b) FTR2 showed an opposite regulation pattern with its expression rising with the increase of iron concentration; and (c) FTH2, FET3 and FET33 exhibited iron-independent expression. Furthermore, the expression levels of the genes varied widely. In the ironchelated medium without added FeCl 3 , the relative expression levels of FTR1, FTR2, FTH1, FET31, FET34 and FET99 were 2.731, 0.008, 0.224, 0.106, 0.730 and 0.677, respectively, while those of the constitutive FTH2, FET3 and FET33 were 0.039, 0.014 and 0.031, indicating that under iron-limiting conditions Ftr1 and Fth1 are the predominant iron permeases and Fet34 and Fet99 the predominant ferroxidases. In comparison, at 1000 mM FeCl 3 , the transcript levels of FTR1 and FTH1 dropped 21 and 37 fold to 0.134 and 0.006, respectively, and that of FTR2 increased 11 fold to 0.102, indicating that under iron-sufficient conditions Ftr1 and Ftr2 exist at comparable amounts and are the major permeases which are 26 and 22 times that of Fth1 and 3.71 and 3.14 times that of Fth2 respectively. Also, at 1000 mM FeCl 3 , the levels of the ferroxidase transcripts ranged from 0.01 to 0.06 with Fet99 the most abundant. Taken together, the analyses reveal that at any iron concentration a subset of permease and ferroxidase exists in C. albicans cells and their exact composition and level are governed by iron concentration.
Subcellular localization of ferroxidases and iron permeases
As co-existence of a permease and a ferroxidase at the PM or VM would suggest a partnership, we first examined the cellular localization of all permeases and ferroxidases. The ferroxidases were tagged with GFP and permeases with mCherry (mCh) both at the C-terminus. Previous studies had shown that the C-terminal tagging had no effect on the localization and function of the proteins (Ramanan and Wang, 2000; Singh et al., 2006) .
All genes were expressed from their own promoter except FET3 which was driven by the MET3 promoter because its natural expression level was below the limit of detection. Cells were grown in either iron-limiting or iron-rich media to allow the expression of different genes. Figure 2A shows that in low-iron media, Fet3, Fet31 and Fet99 localized to both the PM and VM with similar intensities, while Fet34 localized predominantly to the PM and Fet33 seemingly exclusively to the VM. Figure 2B demonstrates that Ftr1 and Ftr2 localized to the PM while Fth1 and Fth2 localized to the VM, confirming that Ftr1 and Ftr2 are PM permeases and Fth1 and Fth2 VM permeases. The VM localization was confirmed by co-staining with the lipophilic dye FM4-64, and Fig. 2C shows representative images. The results Fig. 1 . qPCR analysis of iron permease and ferroxidase gene expression in response to iron concentration. WT C. albicans (SC5314) cells were grown in GMM containing 1 mM ferrozine, 10 mM ascorbic acid and different concentrations of FeCl 3 to the log phase before total RNA extraction. The mRNA level of each gene was analyzed by qPCR using a pair of specific oligonucleotide primers (Supporting Information Table S2 ). The housekeeping gene ACT1 was included for normalization. The experiments were repeated three times, and the error bars show standard deviation. The strains used were YZM34, YZM12, YZM38, YZM23, YZM15, YZM01, YZM16, YZM11 and YZM10. Cells were grown in low (L) or high-iron (H) media which were GMM containing 1 mM ferrozine, 10 mM ascorbic acid and 1 or 1000 lM FeCl 3 at 308C to the log phase before examination with differential interference contrast (DIC) and fluorescence microscopy. The images show the cellular localization of ferroxidase (A) and permeases (B). Cells were grown in high or low-iron media according to the iron dependence of a gene. C. Cellular localization of Fet3 and Fet31 ferroxidases to the VM was confirmed by co-staining with FM4-64. Size bars, 5 mm. also suggest that Fet3, Fet31, Fet34 and Fet99 may associate with both the PM and VM permeases, while Fet33 only with VM permeases. The same localization patterns were also observed in hyphae (Supporting Information Fig. S1 ), indicating that the cellular localization of these proteins is not differentially regulated in different growth modes.
Previous studies have demonstrated that the two subunits of an iron transporter are interdependent for proper folding and trafficking to the correct cellular localization (Stearman et al., 1996; Singh et al., 2006) . If one subunit is missing, the other fails to leave the ER. Thus, if Fet3, Fet31, Fet34 and Fet99 can all form a complex with Ftr1 and Fth1 as suggested by the localization study above, we predicted that the four ferroxidases would all localize predominantly to the VM in ftr1D/D cells and to the PM in fth1D/D cells under iron-limiting conditions in which the expression levels of FTR2 and FTH2 are very low. Similarly, Ftr1 and Ftr2 would not be able to localize to the PM in a mutant lacking all four PM ferroxidases (4fetsD/D; see below for construction), and Fth1 and Fth2 would fail to localize to the VM in a mutant lacking all five ferroxidases (5fetsD/D). To test this hypothesis, we examined the localization of all ferroxidases in ftr1D/D and fth1D/D mutants. As expected, none of the five ferroxidases were detectable at the PM in ftr1D/D and instead they localized strongly at the VM when grown in low-iron medium (Fig. 3A, left) ; and all ferroxidases except Fet33 were seen predominantly at the PM in the fth1D/D mutant. In contrast, when grown in the high-iron medium, all ferroxidases except Fet33 were seen at the PM because of FTR2 expression (Fig.  3A, right) . However, the localization of all ferroxidases except Fet33 at the VM was barely detectable in fth1D/D cells, suggesting that their main partner is Fth1 at the VM. In the 4fetsD/D mutant with all four PM ferroxidase genes deleted, both Ftr1 and Ftr2 failed to localize to the PM (Fig. 3B) . Furthermore, in the 4fetsD/D and fet33D/D mutants, Fth1 and Fth2 could still localize to the VM, and only when all five ferroxidase genes were deleted (5fetsD/D), their VM localization was abolished. The results suggest that except for Fet33 that is specific to VM permeases, all other ferroxidases can form complexes with both PM and VM permeases.
Ferroxidase-permease interaction in live cells
Bimolecular fluorescence complementation (BiFC) has been used extensively to demonstrate protein-protein interaction in live cells (Ventura, 2011; Miller et al., 2015) . This method is based on the reconstitution of a fluorescent protein from its two non-fluorescent halves brought together through fusion with two interacting proteins in the cell. This assay was ideal for establishing the ferroxidasepermease partnership. However, it had not been applied in C. albicans. One main obstacle was that C. albicans uses an unconventional genetic code and translates the standard leucine CUG codon as serine (Santos et al., 1997) . To adapt BiFC to C. albicans, we used the commercial plasmids for S. cerevisiae BiFC assays as templates to clone the N-terminal (VN) and C-terminal (VC) halves of the Venus yellow fluorescence protein in plasmids appropriate for expression in C. albicans and mutated all 21 CTG codons to TTG that encodes leucine. To test whether the modified BiFC system could function in C. albicans, we fused the VN half to a ferroxidase and the VC half to a permease both at the C-terminus, as previous studies had shown that the C-terminal end of both ferroxidases and permeases were on the cytoplasmic side (Singh et al., 2006) . To ensure expression, we expressed all the fusion proteins except Ftr1 and Fet34 under the transcriptional control of the MET3 promoter. We found that cells co-expressing Ftr1-VC with Fet3-VN, Fet31-VN, Fet34-VN or Fet99-VN all showed bright, specific staining of the PM while those co-expressing Fth1-VC with any one of the five VN-tagged ferroxidases exhibited specific staining of the VM (Fig. 4A and B) .
Furthermore, cells co-expressing Ftr1-VC and Fth1-VC with any one of Fet3-VN, Fet31-VN, Fet34-VN and Fet99-VN, displayed staining of both the PM and VM. Like Ftr1, Ftr2 also showed interaction with Fet3-VN, Fet31-VN, Fet34-VN and Fet99-VN (Fig. 4A) . For negative controls, C. albicans cells expressing Fet33-VN or Ftr1-VC alone and cells co-expressing Ftr1-VC (a PM permease) and Fet33-VN (a VM ferroxidase) did not exhibit any specific fluorescent staining of the cell (Fig.  4C ). Fth2's interaction with ferroxidases could not be studied because its expression level was very low regardless of the promoter. Together, we have successfully adapted BiFC for use in C. albicans and discovered a highly flexible partnership between ferroxidases and iron permeases in C. albicans. Our findings dispute the classical view that the ferroxidase-permease interaction is highly specific and subunit exchange does not occur between the PM and VM complexes (Stearman et al., 1996; Spizzo et al., 1997; Urbanowski and Piper, 1999) .
Role of individual ferroxidases and permeases for growth in iron-limiting media
The presence of five ferroxidases and four iron permeases in C. albicans raised the question of whether the homologs were functionally redundant or different. To address this issue, we first compared the growth of mutants lacking a single ferroxidase or permease in iron-limiting and replete media. On GMM plates which are iron rich, all mutants showed no growth defect as compared to WT (Fig. 5A and B, high iron) . However, on the iron-limiting GMM plates supplemented with 1 mM ferrozine, an iron chelator, several mutants exhibited significant growth deficiency. While the ftr1D/D and ftr1D/D ftr2D/D mutants expectedly failed to grow (Ramanan and Wang, 2000) , the fth1D/D, fth2D/D and ftr2D/D mutants had no growth defect (Fig. 5A) . Among the ferroxidase mutants, fet3D/D, fet31D/D, fet33D/D and fet34D/D grew as well as the WT strain while fet99D/D showed markedly slower growth (Fig. 5B, low iron) . The results indicate that in spite of significant functional redundancy among the ferroxidases, Fet99 plays a more important role in iron uptake under iron-limiting conditions. Also, the normal growth of all mutants under ironsufficient conditions indicated that the growth defect exhibited by some mutants under iron-limiting conditions was the specific result of the disruption of high-affinity iron uptake.
Next, we determined whether any single PM ferroxidase gene driven by its own promoter is sufficient to support cell growth under iron-limiting conditions. We constructed mutants that expressed only one of the four PM ferroxidases Fet3, Fet31, Fet34 and Fet99. These four genes are located in a cluster on chromosome 6 in the order of FET31-FET99-FET3-FET34 which allowed us to delete all four genes in a single knockout, yielding 4fetsD/D that does not have any high-affinity iron transporter at the PM and cannot grow on iron-limiting plates (Fig. 5B) . We then reintroduced individual FET genes together with a 1 Kb promoter region back into 4fetsD/D to generate 4fetsD/D:FET3, 4fetsD/D:FET31 and 4fetsD/ D:FET99. The reintroduced gene had a C-terminal GFP tag. For unknown reasons, we encountered great difficulty to clone the full-length FET34. Alternatively, we deleted FET31-FET99-FET3 or FET99-FET3-FET34 in the cluster to yield the strains that expressed only FET34 (3fetsD/D FET34) or FET31 (3fetsD/D FET31) with C-terminal GFP as the sole PM ferroxidase. The GFP tag permitted us to confirm the expression and cellular localization of the ferroxidase ( Fig. 5D and E) . The Fet3 signal driven by its own promoter was too weak for detection although the MET3-driven version localized to the PM (Fig. 3A) . The iron-dependent growth assay showed that although all the strains expressing a single PM ferroxidase grew normally on iron-replete plates, only 3fetsD/D FET34 could grow and did so at a similar rate as WT on iron-limiting plates (Fig. 5C) . Together with the predominant localization of Fet34 at the PM (Fig. 1) , the data suggest that Fet34 is the main PM ferroxidase for iron acquisition under iron-limiting conditions.
High-affinity iron uptake is required for commensalism C. albicans is a member of the human microbiota, commonly colonizing the GI tract which contains many micro-environments with the iron content determined by Tenfold serial dilutions of the indicated C. albicans strains were spotted on low-iron GMM plates supplemented with 1 mM ferrozine, 10 mM ascorbic acid, 20 lM FeCl 3 and required amino acids as well as on normal GMM as control (high iron). The plates were incubated at 308C for 6 and 2 days respectively. Iron-dependent growth of (A) permease mutants (YZM46, YZM52, YZM81, YZM93 and YZM94), (B) ferroxidase mutants (YZM68, YZM55, YZM56, YZM75, YZM69 and YZM92) and (C) strains expressing a single PM ferroxidase gene (YZM235, YZM150, YZM122, YZM102 and YZM105). D. Confirmation of the expression and correct cellular localization of the ferroxidase in the strains used in C. Cells were grown in lowiron media. Size bars, 5 mm. diverse factors such as the diet, host iron absorption mechanisms, and the various iron uptake systems operated by the trillions of microbial cells (Buhnik-Rosenblau et al., 2012; Kortman et al., 2014) . The bioavailability of iron to C. albicans in the GI tract remains unclear. One can assume that if the GI tract is iron rich for C. albicans, the fungus would not need high-affinity iron uptake transporters for colonization. Conversely, if the GI tract or some of its niches are iron-limiting, the loss of a transporter could compromise C. albicans colonization. To address this issue, we performed pair-wise competition assays between an iron-uptake mutant and a WT strain for GI colonization using an established model (Chen et al., 2011; Prieto et al., 2014; Sem et al., 2016) . Groups (n 5 4 per group) of 8-10 week-old female C57BL/6J mice were given drinking water containing 1 mg ml 21 penicillin and 2 mg ml 21 streptomycin for 5 days. On day 6, each animal was administered by oral gavage with 1 3 10 7 C. albicans yeast cells which were a 1:1 mixture of a mutant and a WT strain. The WT cells were labeled with dTomato (dT). The emission of dT was strong rendering C. albicans colonies expressing it pinkish on plates, permitting easy differentiation from the white unlabeled colonies by naked eye (Fig. 6A ). The dT labelling did not affect cell growth under iron-rich or limiting conditions (Supporting Information Fig. S2 ) and the ability for gut colonization (Fig. 6B) . The antibiotic treatment continued throughout the experiment. Fresh stool pellets from each animal were collected at intervals post gavage, immediately resuspended in cold sterile water, homogenized and serially-diluted before spreading onto YPD plates supplemented with penicillin and streptomycin to prevent bacterial growth. The plates were incubated at 308C for 2 days before counting CFUs, and the percentages of the mutant and WT CFUs were calculated.
The competition experiments demonstrated that neither the ftr1D/D nor the ftr2D/D mutant showed significantly reduced ability to compete with the WT strain ( Fig. 6C and D) . Strikingly, the ftr1D/D ftr2D/D mutant exhibited a significant disadvantage in the competition with the WT strain (Fig. 6E) : the percentage of the mutant CFUs in the stool was 30% at 10 h post gavage and fell progressively to 23% at 96 h, indicating that the PM iron uptake system is required for the optimal growth and colonization of C. albicans in the GI tract. The normal colonization of ftr1D/D and ftr2D/D indicates that both genes can be activated in the gut and either one is sufficient to satisfy the iron need of C. albicans.
The ferroxidase mutants showed varying abilities to compete with WT. The fet34D/D mutant was significantly less competitive than WT (Fig. 6G) , while fet99D/D was comparable to WT (Fig. 6H) . The 4fetsD/D mutant phenocopied ftr1D/D ftr2D/D (Fig. 6I) , failing to compete with WT from early stages of the colonization and the mutant CFUs accounted for only 20% of C. albicans CFUs in the stool at 96 h. The shared defects between the ftr1D/ D ftr2D/D and 4fetsD/D mutants are consistent with their lacking any functional high-affinity iron transporter at the PM. The results suggest that the five ferroxidases might have distinct roles in GI niches with different iron availability. Taken together, our findings demonstrate the importance of the high-affinity iron uptake system for C. albicans during its commensal residence in the GI tract in addition to its essentiality for systemic infection (Ramanan and Wang, 2000) . The data also provide evidence that iron is not readily available in the GI tract from the perspective of C. albicans and perhaps other commensal pathogens.
Virulence of C. albicans ferroxidase mutants during systemic infection of mice
Next, we evaluated the importance of the ferroxidases and permeases to the virulence of C. albicans by testing the mutants using the mouse model of systemic infection. Approximately 2 3 10 5 yeast cells of each strain were injected into each mouse via the tail vein. The mice were monitored for survival up to 35 days. The WT strain was BWP17 with URA3, ARG4 and HIS1 reintegrated into the untranslated region (UTR) of the GAL4 gene. All mice injected with the WT strain died within 15 days while some mutants showed different degrees of reduced virulence (Fig. 7A ). As expected, the 4fetsD/D and 5fetsD/D mutants, which lack the high-affinity iron uptake system, showed significantly diminished virulence with 80% of the infected mice surviving on day 35. Among the mutants with a single ferroxidase gene deleted, only fet34D/D showed significantly reduced virulence, killing 50% of the mice on day 35. None of the other single-ferroxidase deletion had a significant effect, indicating functional redundancy among the ferroxidases for systemic infection. We also examined the virulence of select mutants expressing only one PM ferroxidase including 5fetsD/D:FET31, 5fetsD/D:FET99, 3fetsD/D FET31 and 3fetsD/D FET34 ( Fig. 7B and C) . Although all the mutants exhibited higher virulence than 4fetsD/D, none could restore the virulence to the WT level, indicating that more than one PM ferroxidases are required for C. albicans to express its full virulence during systemic infection.
Discussion
We previously found that C. albicans has two PM highaffinity iron permeases Ftr1 and Ftr2 (Ramanan and Wang, 2000) with opposite expression patterns in response to iron concentration. However, its significance was unclear. C. albicans genome sequencing revealed four iron permeases and five ferroxidase genes, suggesting the presence of multiple high-affinity iron transporters. In this study, we first used qPCR to determine the expression profiles of all the ferroxidase and permease genes in C. albicans over a wide range of iron concentrations and found three distinct patterns: (a) FTR1, FTH1, FET31, FET34 and FET99 are down-regulated by high and up-regulated by low iron concentrations, (b) FTR2 is regulated in an opposite manner and (c) the expression of FTH2, FET3 and FET33 is independent of iron concentration. Also, the mRNA levels of the genes varied widely. For example, among the permeases, the level of FTR1 mRNA is 340, 12.14 and 91 times that of FTR2, FTH1 and FTH2, respectively, in the medium with no added FeCl 3 (Fig. 1) , and among the ferroxidases, FET99 shows the highest level being 42.3, 6.39, 27.08 and 0.92 times that of FET3, FET31, FET33 and FET34 respectively. Interestingly, even under iron limitation, FET99's expression is 2-3 times higher than that of the constitutively expressed FET3 and FET33. We believe that the three expression patterns of the ferroxidase and permease genes are an essential feature of an evolutionary product that ensures the presence of a select set of high-affinity iron transporters at any iron concentration (see Fig. 8 for model) . Interestingly, an analysis of response gene expression during invasive C. albicans infection of the kidney of mice revealed 35-60 fold up-regulation of FTR1 and twofold up-regulation of FTR2, indicating that both Ftr1 and Ftr2 transporters were operating during the infection (Xu et al., 2015) .
The high-affinity iron transporter has been extensively investigated in S. cerevisiae Stearman et al., 1996; Severance et al., 2004; Philpott, 2006; Singh et al., 2006) . The ferroxidase-permease interaction was thought to be highly specific in that subunits do not exchange between PM and VM transporters (Stearman et al., 1996; Sato et al., 2004) . The discovery of multiple ferroxidases and permeases in C. albicans questioned the rules that govern the ferroxidase-permease interaction in this fungus. This is an important issue because a strict ferroxidase-permease partnership would yield only a few transporters but a flexible one would allow up to 20 possible combinations. To address this issue, we first determined the cellular localization of all ferroxidases and permeases in WT strains and mutants lacking a permease gene. The results confirmed that Ftr1 and Ftr2 are PM permeases and Fth1 and Fth2 are VM permeases. We further discovered that four ferroxidases can localize to both the PM and VM in a manner dependent on which permease is present, strongly suggesting that they can partner with both the PM and VM permeases. Only one ferroxidase, Fet33, is specific for VM permeases. Next, we performed BiFC to confirm ferroxidase-permease interactions in live cells (Ventura, 2011; Miller et al., 2015) . We found that all ferroxidases except Fet33 can form a complex with both PM and VM permeases while Fet33 can only partner with VM permeases. The findings reveal a flexible ferroxidasepermease partnership in C. albicans, allowing the assembly of up to 18 high-affinity iron transporters.
The combination of the iron-regulated differential expression and the flexible ferroxidase-permease partnership underlie a robust design of a versatile and dynamic system that can be deftly tuned according to iron availability as illustrated in Fig. 8 . At any point in a broad spectrum of iron concentrations, a distinct set of iron transporters is assembled at a certain level. At the extremes, two entirely different sets of transporters exist. At the low end, Ftr1 associates with four ferroxidases forming four transporters at the PM while Fth1 interacts with all five ferroxidases constructing five transporters at the VM, although the most abundant transporters are . At the high end, fewer transporters are formed including at the VM; also the total level of iron transporters is much lower under high compared to low iron conditions. Between the extremes, there is a continuous shift in both the composition and level of the transporters. We hypothesize that this regulatory design would enable C. albicans to deftly respond to iron availability and, at the same time, strike a delicate balance between acquiring iron and preventing its toxicity.
Are the ferroxidases functionally redundant or distinct? The different expression profiles of the ferroxidase genes suggest different roles. Deletion of FET3, FET31, FET33 or FET34 alone did not affect growth on ironlimiting media while the fet99D/D mutant exhibited a clear growth deficiency. In the systemic infection model, fet34D/D killed 50% of the mice compared to the 100% killing by WT, while deleting other ferroxidase genes individually had insignificant effect. Strains expressing a single PM ferroxidase showed varying degrees of enhanced virulence over 4fetsD/D that lacks all PM ferroxidases and the ones expressing only FET31 or FET34 had the strongest effect. However, none of the ferroxidases alone was sufficient to support the full virulence. The single-gene deletion mutants also exhibited different abilities to compete with WT in GI colonization. The fet34D/D mutant showed a significant loss of competitiveness, while fet99D/D was not noticeably compromised. Together, the results demonstrate functional differentiation as well as redundancy among the ferroxidases. The fet34D/D mutant exhibited consistent deficiency both in vitro and during GI colonization and systemic infection, suggesting a major role in iron acquisition. Intriguingly, while fet99D/D exhibited a significant growth defect on iron-limited plates and fet34D/D did not, fet99D/D showed no obvious deficiency during GI colonization and systemic infection. Although the reason remains unclear, it suggests that the simple in vitro condition cannot fully recapitulate the complex environments in the host. Consistently, comparative analyses of gene regulation pathways between in vitro conditions and during infection of mice have revealed the important principle that virulence is a property that is manifested only in the distinct environment in which host-pathogen interaction occurs (Xu et al., 2015) The GI tract is thought to be replete in iron (Miret et al., 2003) . However, recent studies suggested that parts of the GI tract could be iron limiting. It was shown that iron fortification increases the abundance of enteric pathogens in the gut (Kortman et al., 2012 (Kortman et al., , 2014 . Also, the finding that C. albicans mutants lacking the Sef1 transcription factor that promotes iron uptake or Sfu1, a repressor of iron uptake, both are defective in gut colonization, indicating that the GI tract has both iron-rich and iron-limiting niches (Chen et al., 2011) . We showed that the ftr1D/D ftr2D/D and 4fetsD/D mutants, both lacking any high-affinity iron transporter at the PM, were significantly comprised for GI colonization, indicating that the fungus encountered iron-limiting niches in the GI tract. The observation that both ftr1D/D and ftr2D/D mutants showed no defect in GI colonization provides further support to our hypothesis that having two PM permeases regulated in an opposite manner by iron ensures the presence of at least one permease at any iron concentration. This trait is especially important for commensal-pathogens to rapidly adapt to diverse host niches furnishing iron in different forms and levels. Of note, all Candida species belonging to the CTG clade have multiple ferroxidase and permease genes (Muzzey et al., 2013) . Controlling iron availability might be explored for the management of C. albicans infection.
Experimental procedures
C. albicans strains and culture conditions C. albicans strains were routinely grown in yeast extract peptone medium (YPD; 1.0% yeast extract, 2.0% peptone and 2.0% glucose), glucose minimal media (GMM; 0.67% w/v Yeast Nitrogen Base (YNB) without amino acids, and 2% w/v D-glucose). All solid media contained 2% Bactoagar. To prepare media containing different concentrations of iron, GMM was first depleted of iron by adding 1 mM ferrozine and 10 mM ascorbic acid followed by adding different amounts of FeCl 3 .
Gene deletion
BWP17 (Wilson et al., 1999) was used to generate mutants. The general strategy for gene deletion followed standard procedures (Wilson et al., 1999) . Briefly, the target gene was replaced with the cassette containing a selectable marker gene, URA3, ARG4 or HIS1, flanked with fragments corresponding to 500 bp upstream and downstream flanking sequences of the target gene respectively. Appropriate restriction sites were added to the ends by PCR for cloning and release of the cassette. The entire cassette was cut out and purified to transform BWP17 cells, and the cells were spread onto selection plates. Correct deletion was confirmed by PCR. The heterozygous strain was subjected to a second round of gene deletion using a cassette with a different selectable marker.
tagging (Zeng et al., 2012) . To C-terminal-tag a ferroxidase with GFP, the FET open-reading frame (ORF) was PCRamplified with the restriction sites KpnI and XhoI added to the 5 0 and 3 0 ends respectively. The PCR fragment was cleaved with KpnI and XhoI and then cloned into the KpnIXhoI site on pGFP-URA3 upstream of GFP to create pFETGFP which was linearized at a unique site within the ORF and transformed into BWP17. To express FET3 under the MET3 promoter, the pP MET3 GFP vector (Zeng et al., 2012) was used. The FET3 ORF was PCR-amplified with BamHI and XhoI sites added to the 5 0 and 3 0 ends respectively. The PCR fragment was cleaved with BamHI and XhoI and cloned into the BamHI-XhoI site on pP MET3 GFP to create pP MET3 FET3GFP which was cut at a unique site in the MET3 promoter before transformation. To C-terminaltag Ftr1, Ftr2, Fth1 and Fth2 with mCherry. The ORF of the target gene was PCR-amplified with KpnI and XhoI sites added to the 5 0 and 3 0 ends of the PCR fragment respectively. The PCR fragment was cleaved with KpnI and XhoI and then cloned into the KpnI-XhoI site of pmCherry-Arg4 upstream of mCherry. The resulting plasmids were cut at a unique site within the ORF before transforming C. albicans cells.
BiFC assay
The commercial plasmids for S. cerevisiae containing the Venus fragments pFA6a-Venus N-terminal (VN)-HISMX6 and pFA6a-Venus C-terminal (VC)-TRP1 (Euroscarf, Germany) were used as templates to amplify the VN (1-520) and VC (465-722) sequences by PCR with XhoI and ClaI sites were added to the 5 0 and 3 0 ends of both fragments. All CTG codons were mutated to TTG by site-directed mutagenesis. To C-terminal-tag a permease with VC and a ferroxidase with VN, a general strategy similar to the Cterminal tagging of a protein with GFP was used as described above.
Site-directed mutagenesis
Mutagenesis was performed using either the Multi SiteDirected Mutagenesis kit from Aligent Biotechnologies or by PCR-mediated mutagenesis. qPCR mRNA and cDNA were prepared from C. albicans cells as described previously (Nailis et al., 2006) . RT-qPCR was carried out using the Kapa SYBR Fast Universal qPCR kit and the CFX96 Touch Real-Time PCR detection system (Bio-Rad Laboratories, Hercules, CA). The specific primers used are listed in Supporting Information Table S2 . Primer pair stocks were prepared to 5 lM. For each gene, triplicates were set up. Each reaction contained the following: 4 ll primer pair stock (5 lM), 5.2 ll KAPA SYBR FAST Master Mix Universal (23) and 0.8 ll of cDNA in a total volume of 10 ll. The PCR program was: initial denaturation, 958C, 10 min, followed by 40 cycles of denaturation, 958C, 30 s; annealing, 608C, 30 s; and extension, 728C, 30 s. Gene expression levels were calculated using the 2 2DCT method and normalized to the ACT1 housekeeping gene (Livak and Schmittgen, 2001; Nailis et al., 2006) .
Virulence analysis
Female C57BL/6J mice of 8-10 weeks were used. C. albicans was grown in YPD at 308C to the log phase, harvested by centrifugation and washed twice with and resuspended in PBS at a concentration of 1 3 10 6 cells ml
21
. Each mouse was injected via the tail vein with 2 3 10 5 yeast cells and monitored for survival up to 35 days. All animal experiments were conducted according to the rules and guidelines of the Agri-Food and Veterinary Authority and the National Advisory Committee for Laboratory Animal Research, Singapore. The experiments were approved by the Institutional Animal Care and Use Committee of the Biological Resource Center, Singapore (IACUC protocol 151010).
Competitive commensalism
We followed a previous protocol (Chen et al., 2011; Prieto et al., 2014) with minor modifications. Groups (n 5 4 per group) of 8-10 week-old female C57BL/6J mice were given 1 mg ml 21 penicillin and 2 mg ml 21 streptomycin in drinking water for 5 days. On day 6, each mouse was inoculated by gavage with 10 7 yeast cells which were a 1:1 mixture of a mutant and WT-dT strain. Mice were kept individually in separate cages which were changed after each time point. The antibiotic treatment continued throughout the experiment. Fresh stools from each animal were collected at 10, 24, 48, 72 and 96 h and immediately homogenized in sterile water. Serial dilutions of the homogenate were spread onto YPD plates supplemented with 50 units ml 21 penicillin and 50 mg ml 21 streptomycin. The plates were incubated at 308C for 2 days before counting the CFUs of the WT and mutant cells under a fluorescence microscope. The percentage of the mutant and WT CFUs was calculated and the statistical significance was determined as described by Sem et al. (2016) .
